Tangen Biosciences, Inc.

📍 Branford, United States🗓 Founded 2013👥 3 employees💰 Last funded Dec 2015
Biotechnology Research🌐 tangenbioscience.com
Website LinkedIn
Tangen Biosciences, Inc. was founded in 2013 and is located in Branford, Connecticut. The company developed the TangenDx™ platform for fast and accurate detection of targeted DNAs and RNAs directly from specimens by using rotary rapid isothermal nucleic acid detection. The Tangen system consists of the TangenDx™ disc and the GeneSpark™ instrument, an automated amplification device. The TangenDx™ platform, which does not require laboratory facilities, is expected to deliver faster, simpler, more sensitive detection at a lower cost than other commercial technologies. Current tests in development include COVID-19, Candida auris, sepsis causing bacterial panel, antibiotic resistance genes, and a fungal blood panel. The system can process samples from whole blood, sputum, skin swabs, nasopharyngeal swabs, etc. The TangenDx FluA/B, RSV, and SARS-CoV-2 Panel assay planned to be released by the upcoming fall season.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Tangen Biosciences, Inc.?
Tangen Biosciences, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Tangen Biosciences, Inc. last raise funding?
The most recent investment in Tangen Biosciences, Inc. recorded on gritt.io was in December 2015.
When was Tangen Biosciences, Inc. founded?
Tangen Biosciences, Inc. was founded in 2013.
What industry is Tangen Biosciences, Inc. in?
Tangen Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tangen Biosciences, Inc. based?
Tangen Biosciences, Inc. is headquartered in Branford, United States.